A
Abbott India Ltd
NSE:ABBOTINDIA
Abbott India Ltd
NSE:ABBOTINDIA
Price:
25 774.95 INR
-1.42%
Market Closed
Updated:
May 6, 2024
Abbott India Ltd
Net Income (Common)
|
Abbott India Ltd
Net Income (Common) Peer Comparison
Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
A
|
Abbott India Ltd
NSE:ABBOTINDIA
|
Net Income (Common)
₹9.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
19%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Net Income (Common)
₹52.3B
|
CAGR 3-Years
34%
|
CAGR 5-Years
24%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Net Income (Common)
₹37.1B
|
CAGR 3-Years
18%
|
CAGR 5-Years
23%
|
CAGR 10-Years
10%
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Net Income (Common)
₹89.1B
|
CAGR 3-Years
55%
|
CAGR 5-Years
21%
|
CAGR 10-Years
13%
|
|
|
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
|
Net Income (Common)
₹29.7B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Net Income (Common)
₹15B
|
CAGR 3-Years
7%
|
CAGR 5-Years
13%
|
CAGR 10-Years
11%
|
See Also
What is Abbott India Ltd's Net Income (Common)?
Net Income (Common)
9.5B
INR
9.5B
INR
Based on the financial report for Mar 31, 2023, Abbott India Ltd's Net Income (Common) amounts to 9.5B INR.
What is Abbott India Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
19%
19%
Over the last year, the Net Income (Common) growth was 19%. The average annual Net Income (Common) growth rates for Abbott India Ltd have been 17% over the past three years , 19% over the past five years .
You don't have any saved screeners yet
